Clincosm LogoSign in Get a demo

nasopharyngeal carcinoma

Showing 1 - 25 of 346
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nasopharyngeal Carcinoma Trial in Shanghai (Anti-EGFR and PD-1 inhibitor arm)

Recruiting
  • Nasopharyngeal Carcinoma
  • Anti-EGFR and PD-1 inhibitor arm
  • Shanghai, Shanghai, China
    Eye & ENT Hospital of Fudan University
Nov 26, 2023

Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity

Not yet recruiting
  • Nasopharyngeal Carcinoma
    • Fuzhou, Fujian, China
      Department of radiation oncology, Fujian cancer hospital
    Nov 16, 2023

    Nasopharyngeal Carcinoma Screening Based on Tongue Imaging

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • Tongue image
    • Zhuhai, China
      The Fifth Affiliated Hospital of Sun Yat sen University
    Nov 10, 2023

    Nasopharyngeal Carcinoma Trial in Guangzhou (BL-B01D1, capecitabine, gemcitabine)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Oct 31, 2023

    Nasopharyngeal Carcinoma Trial in Wuhan (KSD-101)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • KSD-101
    • Wuhan, China
      Tongji Hospital, Tongji Medical College, Huazhong University of
    Oct 19, 2023

    Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • without concurrent cisplatin chemotherapy
    • with concurrent cisplatin chemotherapy
    • Fuzhou, Fujian, China
      Department of radiation oncology, Fujian cancer hospital
    Oct 18, 2023

    Nasopharyngeal Carcinoma, De-escalation Therapy Trial in Guangzhou (Cisplatin-based induction chemo, Full course of PD-1/PD-L1

    Recruiting
    • Nasopharyngeal Carcinoma
    • De-escalation Therapy
    • Cisplatin-based induction chemotherapy
    • +4 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Oct 16, 2023

    Nasopharyngeal Carcinoma Trial in Singapore (CCRT with Maintenance Tislelizumab and Metronomic Capecitabine)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • CCRT with Maintenance Tislelizumab and Metronomic Capecitabine
    • Singapore, Singapore
    • +1 more
    Oct 16, 2023

    Nasopharyngeal Carcinoma Trial (Envafolimab and recombinant human endostatin combined with chemoradiotherapy)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • Envafolimab and recombinant human endostatin combined with chemoradiotherapy
    • (no location specified)
    Sep 23, 2023

    Nasopharyngeal Carcinoma Trial in Hangzhou (Endostar and Envafolimab)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Endostar and Envafolimab
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Sep 24, 2023

    Predict Severe Oral Mucositis Associated With Chemoradiotherapy

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • Oral Mucositis
    • observational group
    • (no location specified)
    Sep 11, 2023

    Nasopharyngeal Carcinoma Trial (procedure, drug, biological)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • Biospecimen Collection
    • +9 more
    • (no location specified)
    Sep 12, 2023

    Nasopharyngeal Carcinoma Trial in Xi'an (gemcitabine,nimotuzumab, toripalimab, gemcitabine, cisplatin)

    Recruiting
    • Nasopharyngeal Carcinoma
    • gemcitabine,nimotuzumab, toripalimab
    • gemcitabine, cisplatin
    • Xi'an, Shaanxi, China
      Department of Radiation Oncology, Xijing Hospital, Fourth Milita
    Sep 5, 2023

    Nasopharyngeal Carcinoma, Nasopharyngeal Cancer, Nasopharyngeal Tumors Trial in Germany (drug, radiation, procedure, behavioral)

    Recruiting
    • Nasopharyngeal Carcinoma
    • +3 more
    • Aachen, Germany
    • +28 more
    Aug 24, 2023

    Nasopharyngeal Carcinoma, Intensity-Modulated Radiotherapy Trial in Zhongshan (Reduction CTVp1, Non-reduction CTVp1)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Intensity-Modulated Radiotherapy
    • Reduction CTVp1
    • Non-reduction CTVp1
    • Zhongshan, Guangdong, China
      Zhongshan City People's Hospital
    Aug 8, 2023

    Nasopharyngeal Carcinoma Trial in Zhongshan (Anrotinib plus Tirelizumab)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Anrotinib plus Tirelizumab
    • Zhongshan, Guangdong, China
      Zhongshan City People's Hospital
    Jul 31, 2023

    Nasopharyngeal Carcinoma Trial in Guangzhou, Zhongshan, Nanning (IMRT and concurrent cisplatin, gemcitabine and cisplatin

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • IMRT and concurrent cisplatin
    • gemcitabine and cisplatin (Induction chemotherapy)
    • Guangzhou, Guangdong, China
    • +3 more
    Jul 30, 2023

    NSCLC, Nasopharyngeal Carcinoma Trial in China (BL-B01D1, SI-B003)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Nasopharyngeal Carcinoma
    • Chongqing, Chongqing, China
    • +15 more
    Jul 13, 2023

    Head Neck Cancer, Cervical Cancer, Endometrial Cancer Trial (ILB-2109, Toripalimab)

    Not yet recruiting
    • Head and Neck Cancer
    • +9 more
    • (no location specified)
    Jul 12, 2023

    Reveals Relationship Between gp42-IgG Epitopes and

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • Epitope exploration
    • (no location specified)
    Jul 16, 2023

    Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy Trial (radiation, drug, biological)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • +3 more
    • Intensity Modulated Radiation Therapy
    • +3 more
    • (no location specified)
    Jul 11, 2023

    Nasopharyngeal Carcinoma, Iron-deficiency, Anemia Trial in Guangzhou (Iron Isomaltoside 1000, Polysaccharide Iron Complex Pill,

    Recruiting
    • Nasopharyngeal Carcinoma
    • +2 more
    • Iron Isomaltoside 1000
    • +2 more
    • Guangzhou, Guangdong, China
      Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
    Jun 19, 2023

    Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitors Trial (Cadonilimab, Gemcitabine, Cisplatin)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • Immune Checkpoint Inhibitors
    • (no location specified)
    Jun 1, 2023

    Nasopharyngeal Carcinoma, Radiation-induced Oral Mucositis, Bacterial Colonization Trial in Nanchang (Mupirocin Ointment)

    Recruiting
    • Nasopharyngeal Carcinoma
    • +3 more
    • Mupirocin Ointment
    • Nanchang, Jiangxi, China
      Jiangxi Cancer Hospital
    Jun 6, 2023

    Nasopharyngeal Carcinoma Trial in Zhongshan (participants will undergo dual-energy CT and endoscopy)

    Recruiting
    • Nasopharyngeal Carcinoma
    • participants will undergo dual-energy CT and endoscopy
    • Zhongshan, Guangdong, China
      Zhongshan People's Hospital
    May 22, 2023